会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Moisture-vapor-permeable dressing
    • 水分透湿敷料
    • US5322695A
    • 1994-06-21
    • US932747
    • 1992-08-25
    • Kishore R. ShahAgis KydonieusDimitrios Apostolopoulos
    • Kishore R. ShahAgis KydonieusDimitrios Apostolopoulos
    • A61K9/70A61L15/44A61L15/58A61L15/00A61F13/00
    • A61K9/7084A61L15/44A61L15/58A61L2300/202A61L2300/206A61L2300/222A61L2300/404A61L2300/408
    • Described is a moisture-vapor-permeable and oxygen-permeable adhesive dressing for use in supplying a topical medicament to human skin in a controlled release manner, which dressing is unaffected by and impermeable to water in the liquid phase, which dressing when in use on human skin consists essentially of:(i) a polymeric backing material lamina having two surfaces, a first substantially planar surface and a second substantially planar surface;(ii) adhering to said first planar surface of said backing material a medication reservoir lamina having two surfaces, a first substantially planar surface and a second substantially planar surface, consisting essentially of an intimate mixture of:(a) a polyvinyl chloride polymer;(b) a polymeric plasticizer intimately admixed with said polyvinyl chloride and compatible with said polyvinyl chloride; and(c) a topical medicament compatible with said polyvinyl chloride and said plasticizer;said first substantially planar surface of said medication reservoir lamina adhering to said first substantially planar surface of said backing material in a continuous or discontinuous manner; and(iii) adhering to said second substantially planar surface of said medication reservoir lamina, a pressure-sensitive adhesive which is permeable to oxygen and moisture vapor but is unaffected by liquid water.
    • 描述了一种用于以控制释放的方式向人体皮肤供应局部药物的透湿透湿粘合剂,该敷料不受液相中的水的影响,并且不透水。 人体皮肤基本上由以下部分组成:(i)具有两个表面的聚合物背衬材料层,第一基本上平坦的表面和第二基本平坦的表面; (ii)粘附在所述背衬材料的所述第一平坦表面上,具有两个表面的药物储存器层,第一基本上平坦的表面和第二基本平坦的表面,其基本上由以下组成的紧密混合物组成:(a)聚氯乙烯聚合物; (b)与所述聚氯乙烯密切混合并与所述聚氯乙烯相容的聚合物增塑剂; 和(c)与所述聚氯乙烯和所述增塑剂相容的局部药物; 所述药物储存器层的所述第一基本上平坦的表面以连续或不连续的方式粘附到所述背衬材料的所述第一基本上平坦的表面; 和(iii)粘附到所述药物储存器层的所述第二基本上平坦的表面,压敏粘合剂,其可渗透氧气和水汽,但不受液态水影响。
    • 8. 发明授权
    • Article useful for administration of pharmacologically-active substances
transdermally, orally, or by means of implant
    • 用于透皮,口服或通过植入物施用药理活性物质的制品
    • US4758434A
    • 1988-07-19
    • US847635
    • 1986-04-03
    • Agis KydonieusKishore R. ShahBret Berner
    • Agis KydonieusKishore R. ShahBret Berner
    • A61K9/70A61K31/21A61M31/00A61L15/03A61F13/00
    • A61K9/703A61K31/21A61K9/7084A61M31/002
    • Described is an article of manufacture useful for administration of pharmacologically-active substances, transdermally, orally or by means of subdermal implant comprising a solid vinyl plastisol layer for contacting a patient's tissue, internally or externally, the layer containing from about 20 up to about 70% by weight of a polyvinyl chloride resin or a polyvinyl chloride-polyvinyl acetate copolymer containing a minor proportion of vinyl acetate; from about 20-70% plasticizer composition; from abotu 0.5 up to 35% of pharmacologically-active substance such as isosorbide dinitrate, nicotine, clonidine, guanfacine, indomethacin, glyceryl trinitrate and prostaglandin and optionally excipients. Also described is the novel plasticizer-polyvinyl chloride composition of matter comprising 1-dodecylhexahydro-2H-azepin-2-one and polyvinyl chloride resin taken together with a pharmacologically-active substance whereint he 1-dodecylhexahydro-2H-azepin-2-one not only acts as a plasticizer but also acts as a penetration enhancer (through tissue) for the pharmacologically-active substance.
    • 描述了可用于施用药理学活性物质,经皮,口服或通过皮下植入的制剂,其包括固体乙烯基增塑溶胶层,用于在内部或外部将患者组织接触含有约20至约70的层 重量百分比的聚氯乙烯树脂或含有少量醋酸乙烯酯的聚氯乙烯 - 聚乙酸乙烯酯共聚物; 约20-70%的增塑剂组成; 来自abotu 0.5至35%的药理活性物质如硝酸异山梨酯,尼古丁,可乐定,胍法西林,吲哚美辛,三硝酸甘油酯和前列腺素以及任选的赋形剂。 还描述了包含1-十二烷基六氢-2H-氮杂-2-酮和聚氯乙烯树脂与药物活性物质一起的新型增塑剂 - 聚氯乙烯组合物,其中1-十二烷基六氢-2H-氮杂-2-酮不包括 仅用作增塑剂,但也用作药理活性物质的渗透促进剂(通过组织)。